Multiparametric MRI of the Prostate as a Tool for Prostate Cancer Detection, Localization, and Risk Assessment

2016 ◽  
pp. 107-126
Author(s):  
Marc A. Bjurlin ◽  
Neil Mendhiratta ◽  
Samir S. Taneja
2020 ◽  
Vol 53 (1) ◽  
pp. 283-291
Author(s):  
Tsutomu Tamada ◽  
Ayumu Kido ◽  
Akira Yamamoto ◽  
Mitsuru Takeuchi ◽  
Yoshiyuki Miyaji ◽  
...  

2018 ◽  
Vol 44 (6) ◽  
pp. 1129-1138 ◽  
Author(s):  
Thais Caldara Mussi ◽  
Tatiana Martins ◽  
George Caldas Dantas ◽  
Rodrigo Gobbo Garcia ◽  
Renee Zon Filippi ◽  
...  

2019 ◽  
Vol 52 (4) ◽  
pp. 633-638
Author(s):  
Dordaneh Sugano ◽  
Abhinav Sidana ◽  
Amit L. Jain ◽  
Brian Calio ◽  
Sonia Gaur ◽  
...  

2013 ◽  
Vol 39 (5) ◽  
pp. 1206-1212 ◽  
Author(s):  
Antonella Petrillo ◽  
Roberta Fusco ◽  
Sergio V. Setola ◽  
Francesco M. Ronza ◽  
Vincenza Granata ◽  
...  

2017 ◽  
Vol 11 (4) ◽  
pp. 201-205 ◽  
Author(s):  
Takeshi Hara ◽  
Takeshi Ogata ◽  
Hiroko Wada ◽  
Takayuki Yabuki ◽  
Susumu Kanazawa

Introduction: Gadobutrol (Gd-DO3A-butrol) (Gadovist®) is a macrocyclic gadolinium-based contrast agent for magnetic resonance imaging (MRI) formulated at 1.0 mmol Gd/ml. Gadobutrol's higher concentration compared to other contrast agents (0.5 mmol Gd/ml) is associated with higher T1 relaxivity. We examined whether gadobutrol increases the accuracy of prostate cancer detection using dynamic contrast-enhanced MRI. Materials and Methods: Multiparametric MRI was performed in 379 patients: 94 patients received 1 M gadobutrol while 285 randomly received equivalent doses of 0.5 M gadoterate meglumine or gadopentetate dimeglumine. MRI images were retrospectively and blindly assessed for the presence of cancer by comparing them with prostate biopsy findings. Results: The specificity and accuracy were significantly higher with 1 M gadobutrol than 0.5 M of the other contrast agents. There were no significant differences in the sensitivity, or positive and negative predictive values. Conclusion: Multiparametric MRI using 1 M gadobutrol may improve the accuracy of prostate cancer detection.


2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Matthew Truong ◽  
Hiroshi Miyamoto ◽  
Eric Weinberg ◽  
Gary Hollenberg ◽  
Edward Messing ◽  
...  

2014 ◽  
Vol 202 (2) ◽  
pp. 343-351 ◽  
Author(s):  
Maarten de Rooij ◽  
Esther H. J. Hamoen ◽  
Jurgen J. Fütterer ◽  
Jelle O. Barentsz ◽  
Maroeska M. Rovers

Sign in / Sign up

Export Citation Format

Share Document